SCHEMBL8649458

SCHEMBL8649458

Cc1ccn(C(C)C(=O)O)c(=O)c1N

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP5 P45974 1/20 0.40
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 2/20 0.37
PTGS2 P35354 4/20 0.36
FPR2 P25090 1/20 0.33
PRNP P04156 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
KMT2A Q03164 1/20 0.31
CSNK2A2 P19784 1/20 0.31
CSNK2B P67870 1/20 0.31
CSNK2A1 P68400 1/20 0.31
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24019686 0.80 SMN1; SMN2 (0.34) ALDH1A1PTGS2RAB9APOLB
Benzene SCHEMBL8402044 0.80 USP5 (0.40) USP5KDM4EALDH1A1PTGS2FPR2
SCHEMBL949093 0.75 PTGS2 (0.46) USP5KDM4EALDH1A1PTGS2FPR2
SCHEMBL3005172 0.72 PARP1 (0.51) USP5KDM4EALDH1A1PTGS2HPGD
SCHEMBL455007 0.70 USP5 (0.40) USP5KDM4EALDH1A1PTGS2FPR2
SCHEMBL30087060 0.69 CRBN (0.46) USP5ALDH1A1PTGS2POLB
SCHEMBL31444926 0.69 USP5 (0.56) USP5KDM4EPTGS2GAACASP1
SCHEMBL312028 0.69 USP5 (0.56) USP5KDM4EPTGS2GAACASP1
SCHEMBL8694192 0.68 KDM4E (0.50) USP5KDM4EALDH1A1PTGS2KMT2A
SCHEMBL24112194 0.66 ATAD2 (0.40) KDM4EALDH1A1PTGS2RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5847135-A Inhibitors of interleukin-1β converting enzyme VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-12-08 US disclosed
US-5716929-A THERAPY FOR INFLAMMATION, AUTOIMMUNE DISEASES VERTEX PHARMACEUTICALS, INC. (US) 1998-02-10 US disclosed